Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.

Postgraduate medicine

Volumn 125, Issue 4, 2013, Pages 181-190

  Manor, Iris ^a   Newcorn, Jeffrey H ^b   Faraone, Stephen V ^b   Adler, Lenard A ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; METADOXINE; PYRIDOXINE; PYROGLUTAMIC ACID;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLASSIFICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM AGENTS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; PYRIDOXINE; PYRROLIDONECARBOXYLIC ACID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885921461     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.07.2689     Document Type: Article

References (0)